2019 Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease. 1st listed author Cappelli B Journal Haematologica.
2019 Optimizing cord blood selection. 1st listed author Ruggeri A Journal Hematology Am Soc Hematol Educ Program.
2019 Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting. 1st listed author Bondanza A Journal Bone Marrow Transplant.
2019 Development of adaptive immune effector therapies in solid tumors. 1st listed author Comoli P Journal Ann Oncol.
2019 Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia. 1st listed author Gratwohl A Journal EClinicalMedicine.
2019 Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). 1st listed author Snowden JA Journal Bone Marrow Transplant.
2019 Hematopoietic cell transplant nurse coordinators' perceptions of related donor care: a European survey from the EBMT Nurses Group. 1st listed author Polomeni A Journal Bone Marrow Transplant.
2019 Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. 1st listed author Inamoto Y Journal Bone Marrow Transplant.
2019 Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia. 1st listed author Schetelig J Journal Leukemia.
2019 Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning. 1st listed author Andersen NS Journal J Cancer Res Clin Oncol.
2019 Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties. 1st listed author Dreger P Journal Bone Marrow Transplant.